Gemcitabine and vinorelbine followed by docetaxel in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial of nonplatinum sequential triplet combination chemotherapy (JMTO LC00-02)

To evaluate the efficacy and toxicity of the sequential nonplatinum combination chemotherapy consisting of gemcitabine (GEM) and vinorelbine (VNR) followed by docetaxel (DOC) in patients with advanced non-small-cell lung cancer (NSCLC), we conducted the multiinstitutional phase II study. A total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosoe, S, Komuta, K, Shibata, K, Harada, H, Iwamoto, Y, Ohsaki, Y, Morioka, T, Origasa, H, Fukushima, M, Furuse, K, Kawahara, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747544/
https://www.ncbi.nlm.nih.gov/pubmed/12569374
http://dx.doi.org/10.1038/sj.bjc.6600723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747544/
https://www.ncbi.nlm.nih.gov/pubmed/12569374
http://dx.doi.org/10.1038/sj.bjc.6600723

Ejemplares similares